X0306 4 2019-04-10 0 0001618835 Evofem Biosciences, Inc. EVFM 0000914208 Invesco Ltd. 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309 0 0 1 0 Right to Purchase 4.50 2019-04-10 4 J 0 2222222 0.0001 A 2019-04-11 2019-06-10 Common Stock 2222222 2777778 I See Footnote Right to Purchase 6.38 2019-04-10 4 J 0 555556 0.0001 A Common Stock 555556 2777778 I See Footnote On April 10, 2019, Invesco Ltd. entered into a Securities Purchase Agreement with the Issuer (the "Securities Purchase Agreement"), pursuant to which Invesco Ltd. has the right, until June 10, 2019, to purchase 2,222,222 shares of common stock at a purchase price of $4.50 per share and warrants to purchase an additional 555,556 shares of common stock at an exercise price equal to $6.38 per share. This number does not include the 212,765 warrants owned by Invesco Ltd. as of the date of this Form 4. Pursuant to the Securities Purchase Agreement, upon and subject to the second closing contemplated therein, Invesco Ltd. will surrender for cancellation warrants to purchase 212,765 shares of common stock existing and outstanding as of the date of the Securities Purchase Agreement. Invesco Ltd. is the beneficial owner of 11,812,910 shares of common stock and warrants to purchase 212,765 common shares acquired by its affiliates, Invesco High Income Fund and Invesco Income Fund. The warrants are exercisable six (6) months following the original issue date The warrants expire seven (7) years following the original issue date. Nancy Tomassone, Global Assurance Officer 2019-04-15